Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹711Cr
Rev Gr TTM
Revenue Growth TTM
35.66%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DMCC
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -5.1 | -24.5 | -26.9 | 11.8 | -13.0 | -0.3 | 34.3 | 46.6 | 49.1 | 48.9 | 22.7 | 27.8 |
| 80 | 75 | 67 | 73 | 77 | 76 | 87 | 100 | 110 | 110 | 112 | 136 |
Operating Profit Operating ProfitCr |
| 16.9 | 12.8 | 12.4 | 8.8 | 8.8 | 10.4 | 14.9 | 15.0 | 12.1 | 13.3 | 11.1 | 9.8 |
Other Income Other IncomeCr | 1 | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Depreciation DepreciationCr | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| 9 | 5 | 4 | 0 | 9 | 2 | 9 | 11 | 9 | 11 | 8 | 9 |
| 3 | 2 | 1 | 0 | 3 | 1 | 3 | 3 | 3 | 3 | 3 | 3 |
|
Growth YoY PAT Growth YoY% | 80.8 | -49.6 | 183.8 | 109.8 | -13.8 | -56.4 | 145.2 | 2,438.7 | 12.1 | 466.4 | -1.0 | -21.6 |
| 6.9 | 3.7 | 3.1 | 0.4 | 6.9 | 1.6 | 5.7 | 6.7 | 5.2 | 6.1 | 4.6 | 4.1 |
| 2.7 | 1.3 | 0.9 | 0.1 | 2.3 | 0.6 | 2.3 | 3.2 | 2.6 | 3.1 | 2.3 | 2.5 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 1.7 | 27.7 | -17.5 | 6.7 | 63.0 | 17.9 | -14.8 | 31.5 | 22.7 |
| 146 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 468 |
Operating Profit Operating ProfitCr |
| 16.9 | 12.9 | 23.5 | 14.8 | 17.7 | 12.5 | 8.8 | 11.1 | 13.2 | 11.5 |
Other Income Other IncomeCr | 1 | 1 | 1 | 6 | 8 | 6 | 5 | 10 | 1 | 1 |
Interest Expense Interest ExpenseCr | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 11 | 8 |
Depreciation DepreciationCr | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 16 |
| 21 | 16 | 47 | 26 | 34 | 34 | 11 | 17 | 31 | 37 |
| 4 | 3 | 1 | -6 | 1 | 13 | 4 | 6 | 10 | 11 |
|
| | -27.9 | 275.3 | -31.8 | 3.5 | -34.5 | -67.5 | 67.2 | 85.8 | 21.5 |
| 9.7 | 6.9 | 20.3 | 16.8 | 16.3 | 6.5 | 1.8 | 3.5 | 5.0 | 4.9 |
| 6.9 | 4.9 | 18.5 | 12.6 | 13.1 | 8.6 | 2.8 | 4.7 | 8.6 | 10.5 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| 35 | 48 | 91 | 120 | 148 | 169 | 173 | 185 | 203 | 209 |
Current Liabilities Current LiabilitiesCr | 71 | 60 | 53 | 47 | 69 | 127 | 132 | 107 | 110 | 107 |
Non Current Liabilities Non Current LiabilitiesCr | 18 | 24 | 20 | 20 | 22 | 63 | 70 | 61 | 43 | 33 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 60 | 65 | 87 | 99 | 91 | 126 | 137 | 115 | 135 | 140 |
Non Current Assets Non Current AssetsCr | 89 | 92 | 102 | 112 | 172 | 258 | 264 | 262 | 245 | 235 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 29 | 18 | 21 | 27 | 32 | 51 | 30 | 38 | 38 |
Investing Cash Flow Investing Cash FlowCr | -8 | -9 | -13 | -17 | -40 | -98 | -21 | -10 | -7 |
Financing Cash Flow Financing Cash FlowCr | -19 | -9 | -8 | -6 | 3 | 45 | -10 | -27 | -30 |
|
Free Cash Flow Free Cash FlowCr | 22 | 10 | 7 | 10 | -10 | -47 | 9 | 19 | 31 |
| 170.1 | 149.4 | 45.2 | 85.8 | 99.0 | 239.6 | 431.1 | 331.1 | 176.7 |
CFO To EBITDA CFO To EBITDA% | 97.7 | 80.2 | 39.0 | 97.0 | 90.8 | 125.8 | 88.1 | 105.8 | 66.7 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 209 | 237 | 366 | 169 | 793 | 908 | 598 | 684 | 749 |
Price To Earnings Price To Earnings | 14.0 | 19.2 | 7.9 | 5.4 | 24.4 | 42.5 | 86.3 | 59.0 | 34.8 |
Price To Sales Price To Sales | 1.2 | 1.3 | 1.6 | 0.9 | 4.0 | 2.8 | 1.6 | 2.1 | 1.7 |
Price To Book Price To Book | 4.0 | 3.3 | 3.2 | 1.2 | 4.6 | 4.7 | 3.0 | 3.3 | 3.3 |
| 7.7 | 11.0 | 7.1 | 6.4 | 23.0 | 24.2 | 20.0 | 20.6 | 13.8 |
Profitability Ratios Profitability Ratios |
| 40.9 | 40.6 | 48.7 | 50.7 | 53.3 | 39.5 | 35.6 | 38.9 | 38.0 |
| 16.9 | 12.9 | 23.5 | 14.8 | 17.7 | 12.5 | 8.8 | 11.1 | 13.2 |
| 9.7 | 6.9 | 20.3 | 16.8 | 16.3 | 6.5 | 1.8 | 3.5 | 5.0 |
| 30.7 | 20.9 | 37.2 | 17.1 | 18.2 | 14.2 | 7.6 | 11.3 | 15.2 |
| 28.5 | 16.9 | 39.9 | 21.7 | 18.8 | 11.0 | 3.5 | 5.5 | 9.5 |
| 11.4 | 7.8 | 24.5 | 14.8 | 12.3 | 5.6 | 1.7 | 3.1 | 5.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **1. Bulk Chemicals**
- **Products:** Sulphuric Acid, Oleum, Chloro Sulphonic Acid, Sulphuric Anhydride (SO₃).
- **Sales Profile:** ~50% domestic (regionally distributed), 50% captive use for downstream specialty chemicals.
- **Capacity & Utilization:** Operating near full capacity (>90%), particularly in sulphuric acid production.
- **Market Dynamics:** Commodity-driven with low margins, high price sensitivity, and dependence on logistics and consistent raw material supply.
- **Recent Developments:**
- A large copper smelter commissioning in Gujarat is expected to increase domestic sulphuric acid supply, likely leading to **near-term price softening**.
- The Roha plant faces a **planned maintenance shutdown in Q1 FY26**, which may impact short-term performance.
### **2. Specialty Chemicals**
- **Products:** Benzene Sulphonate, Phenol Sulphonate, Sulphones, Sodium Vinyl Sulphonate, Diphenyl Sulphone, and downstream sulphur- and boron-based derivatives.
- **Sales Profile:** 65–70% of specialty products are **export-oriented**.
- **Applications:** Pharmaceuticals, agrochemicals, dyes, detergents, pigments, coatings, cosmetics, and ceramics.
- **Segment Evolution:**
- Specialty chemicals accounted for **~44–52% of total revenue in recent years**, depending on cyclical demand.
- The segment has faced **two years of weak demand** due to European destocking, high energy costs, and inflation, leading to **low capacity utilization (50–85%)** and margin pressure.
- Signs of recovery are emerging as customer inventories normalize.
---
## **Key Strategic Developments (2025–2026)**
### **1. Commercial & Export Growth**
- **New Export Opportunities:** DMCC sees **strong export potential in niche, low-volume sulfonation products** in **APAC and LATAM**, driven by Chinese manufacturers moving downstream and reducing their supply in these segments.
- **Geographic Rebalancing:** The company is **reducing reliance on European exports** (which declined from ~60% to under 20% of exports) and **expanding in US, Latin America, and China markets**.
- **Resilience Amid Tariffs:** Despite U.S. tariffs, the company has retained all major export customers—indicating **pricing resilience, product differentiation, and strong customer trust** in key markets.
### **2. Production & Capacity**
- **Facilities Summary:**
| Facility | Location | Area | Focus | Capacity | Key Features |
|--------|--------|------|-------|----------|-------------|
| Roha | Maharashtra | 88,355 sq. m. | Sulphur Chemistry | 350 TPD Sulphuric Acid | R&D center, zero liquid discharge (ZLD), 3 multi-purpose plants, land reserves for future expansion |
| Dahej | Gujarat | 103,327 sq. m. | Sulphur & Boron Chemistry | Expanding capacity | Closer to suppliers, lower logistics cost, ZLD planned, 50% land reserved for growth |
- **Dahej Plant Expansion:** Near completion, it will drive **revenue and margin growth** from higher-margin specialty chemicals and improve logistics efficiency.
- **Underutilized Capacity:** Both sites currently have **ample capacity** to scale quickly as demand recovers—critical for capitalizing on rebound opportunities.
### **3. R&D & Innovation**
- **R&D Center:** Located at Roha and expanding to Dahej; **recognized by CSIR and DSIR**, India.
- **Investment:** ₹1.09 crores in FY24; historically increased to ₹2.25 crores in FY20 (40% YoY growth).
- **Focus Areas:**
- Process optimization and cost reduction.
- Development of high-value, low-volume specialty chemicals.
- Exploration of **advanced reactor technologies (e.g., flow reactors)** to improve yield and safety.
- Innovation in **boron chemistry** (e.g., Zinc Borate, Trimethyl Borate) and **pharmaceutical intermediates** (Sulfones, Thiols, Amides).
- **Commercialization Model:** Full lifecycle integration—from lab to production—with **pilot plants enabling rapid scale-up** and **customer-specific solutions**.
### **4. Boron Chemistry Growth**
- **Products:** Boric Acid, Borax Pentahydrate, Borax Decahydrate, Zinc Borate, Disodium Octaborate, Trimethyl Borate.
- **Market Applications:** Ceramics, detergents, electroplating, steel, and **automotive fluids** (new product under development).
- **Strategic Move:** DMCC is investing in **backward integration and debottlenecking** at its boron facility to reduce costs and enhance production reliability.
- **Financials:** Boron segment generates ~₹100 crore annually and operates near full capacity.
---
## **Financial & Operational Strengths**
- **Revenue Composition (Recent Period):**
- **56% Bulk Chemicals**
- **44% Specialty Chemicals**
- **Exports:** 18–27% of total turnover (down from earlier highs due to weaker European demand).
- **Strong Margins & Resilience:**
- **Long-term contracts with cost pass-through clauses** (1-quarter lag) protect margins from raw material volatility.
- **Backward integration** improves cost control and supply chain resilience.
- **Financial Position:**
- **Minimal debt** (long-term borrowings < ₹60 crores).
- **No major capex planned**; previous investments complete.
- **Disciplined approach to expansion**: Requires 70–80% utilization and strong demand before scaling.
- **Target revenue from current assets:** ~₹500 crores under existing conditions.
---
## **Competitive Advantages**
- **Over 100 Years of Expertise:** Deep technical knowledge in **sulfur chemistry** and **hazardous chemical handling**.
- **High Barriers to Entry:**
- Complex and hazardous chemical processes.
- Lengthy customer approval cycles (6–18 months), leading to **durable, sticky relationships**.
- Strong **regulatory compliance and safety record**.
- **Backward Integration:** Makes DMCC a **low-cost global producer** of key specialty chemicals.
- **Strategic Location:** Dahej’s proximity to key suppliers reduces logistics costs and enhances competitiveness.
- **Flexible Manufacturing Infrastructure:** Mix of **dedicated and multipurpose plants** enables rapid introduction of new products with minimal capital outlay.